Medindia

X

Zohydro may Increase Risk of Addiction, Says FDA Expert Panel

by Kathy Jones on  December 8, 2012 at 7:52 PM Drug News   - G J E 4
An expert panel with the US Food and Drug Administration has recommended the health agency not to approve Zogenix Inc's Zohydro painkiller drug as there is a high risk of addiction among the users.
 Zohydro may Increase Risk of Addiction, Says FDA Expert Panel
Zohydro may Increase Risk of Addiction, Says FDA Expert Panel
Advertisement

The panel voted 11-2 in favor of the recommendation and said that while the San Diego-based pharmaceutical company did manage to meet the narrow targets for safety and efficacy, there is a risk that people who are addicted to other opioid painkillers may also become addicted to Zohydro, generically known as hydrocodone bitartrate.

Advertisement
However the director of FDA's division of anesthesia, Dr Bob Rappaport said that the agency should now decide on whether the panel's recommendation was based on tangible evidence. "Otherwise you're punishing this company and this drug because of the sins of the previous developers and their products. And from a regulatory standpoint, that's not really something we can do", he said.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All